BlueRock Therapeutics

Seth Ettenberg, Ph.D., CEO 

Oct. 11 | 10:00am | Oxford Biomedica Ballroom 

Cambridge, MA 


In-person Presentation 

BlueRock Therapeutics is a leading engineered cell therapy company with a mission to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition. The company’s cell+gene platform harnesses the power of cells to create new medicines for neurology, cardiology, immunology, and ophthalmology indications. BlueRock Therapeutics’ cell differentiation technology recapitulates the cell’s developmental biology to produce authentic cells, some of which are engineered for additional therapeutic function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore lost function. 

By using this website you agree to accept our Privacy Policy and Terms & Conditions